RCAN1 and cancer: KEGG pathway analysis revealed that in both cancers, RCAN1 may be involved positive regulation of cytokine–cytokine regulation, TGF-β signaling, tumor necrosis factor (TNF) signaling, and cell adhesion, and the negative regulation of pyrimidine metabolism, cell cycle, and DNA replication.